Family-based study of markers at the 5′-flanking region of the human dopamine transporter gene reveals potential association with schizophrenic psychoses

European Archives of Psychiatry and Clinical Neuroscience

Volumn 256, Issue 7, 2006, Pages 422-427

  Stöber, Gerald ^a   Sprandel, Julia ^a   Jabs, Burkhard ^a   Pfuhlmann, Bruno ^a   Möller Ehrlich, Kerstin ^a   Knapp, Michael ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Dopamine transporter; Gene; hSLC6A3; Polymorphism; Promoter; Schizophrenia

Indexed keywords

DOPAMINE TRANSPORTER;

ADULT; ALLELE; ARTICLE; DNA FLANKING REGION; FEMALE; GENE; GENE EXPRESSION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC MARKER; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HSLC6A3 GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

5' FLANKING REGION; ADULT; ALLELES; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FAMILY; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA;

EID: 33750069150     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00406-006-0657-3     Document Type: Article

References (45)

1. Carlsson A (1988) The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology 1:179-186
2. Laakso A, Vilkman H, Alakare B, Haaparanta M, Bergman J, Solin O, Peurasaari J, Rakkolainen V, Syvalahti E, Hietala J (2000) Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography. Am J Psychiatry 157:269-271
3. Semwal P, Prasad S, Bhatia T, Deshpande SN, Wood J, Nimgaonkar VL, Thelma BK (2001) Family-based association studies of monoaminergic gene polymorphisms among North Indians with schizophrenia. Mol Psychiatry 6:220-224
4. Bannon MJ, Michelhaugh SK, Wang J, Sacchetti (2001) The human dopamine transporter gene: gene organization, transcriptional regulation, and potential involvelment in neuropsychiatric disorders. Eur Neuropsychopharmacol 11:449-455
5. Uhl GR (2003) Dopamine transporter: Basic science and human variation of a key molecule for dopaminergic function, locomotion, and Parkinsonism. Mov Disorder 18 (Suppl. 7):71-80
6. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Wang ZW, Jabs E (1992) Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14:1104-1106
7. Silverman JM, Greenberg DA, Altstiel LD, Siever LJ, Mohs RC, Smith CJ, Zhou G, Hollander TE, Yang XP, Kedache M, Li G, Zaccario ML, Davis KL (1996) Evidence of a locus for schizophrenia and related disorders on the short arm of chromosome 5 in a large pedigree. Am J Med Genet 67:162-171
8. Cooper-Casey K, Mesen-Fainardi A, Galke-Rollins B, Llach M, Laprade B, Rodriguez C, Riondet S, Bertheau A, Byerley W (2005) Suggestive linkage of schizophrenia to 5p13 in Costa Rica. Mol Psychiatry doi: 10.1038/sj.mp.4001640
9. Crowe RR, Vieland V (1999) Report of the Chromosome 5 Workshop of the Sixth World Congress on Psychiatric Genetics. Am J Med Genet 88:229-232
10. Badner JA, Gershon ES (2002) Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 7:405-411
11. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, Williams NM, Schwab SG, Pulver AE, Faraone SV, Brzustowicz LM, Kaufmann CA, Garver DL, Gurling HM, Lindholm E, Coon H, Moises HW, Byerley W, Shaw SH, Mesen A, Sherrington R, O'Neill FA, Walsh D, Kendler KS, Ekelund J, Paunio T, Lonnqvist J, Peltonen L, O'Donovan MC, Owen MJ, Wildenauer DB, Maier W, Nestadt G, Blouin JL, Antonarakis SE, Mowry BJ, Silverman JM, Crowe RR, Cloninger CR, Tsuang MT, Malaspina D, Harkavy-Friedman JM, Svrakic DM, Bassett AS, Holcomb J, Kalsi G, McQuillin A, Brynjolfson J, Sigmundsson T, Petursson H, Jazin E, Zoega T, Helgason T (2003) Genome scan meta-analysis of schizophrenia and bipolar disorder, Part II: Schizophrenia. Am J Hum Genet 73:34-48
12. Maier W, Minges J, Eckstein N, Brodski C, Albus M, Lerer B, Hallmayer J, Fimmers R, Ackenheil M, Ebstein RE, Borrmann M, Lichtermann D, Wildenauer DB (1996) Genetic relationship between dopamine transporter gene and schizophrenia: linkage and association. Schizophr Res 20:175-180
13. Georgieva L, Dimitrova A, Nikolov I, Koleva S, Tsvetkova R, Owen MJ, Toncheva D, Kirov G (2002) Dopamine transporter gene (DAT1) VNTR polymorphism in major psychiatric disorders: family-based association study in the Bulgarian population. Acta Psychiatr Scand 105:396-399
14. Schmitt GJE, Frodl T, Dresel S, la Fougère C, Bottlender R, Koutsouleris N, Hahn K, Möller HJ, Meisenzahl EM (2005) Striatal dopamine transporter availability is associated with the productive psychotic state in first episode, drug-naive schizophrenic patients. Eur Arch Psychiatry Clin Neurosci DOI: 10.1007/s00406-005-0618-2
15. Gamma F, Faraone SV, Glatt SJ, Yeh YC, Tsuang MT (2005) Meta-analysis shows schizophrenia is not associated with the 40-base-pair repeat polymorphism of the dopamine transporter gene. Schizophr Res 73:55-58
16. Jeong SH, Joo EJ, Ahn YM, Kim YS (2004) Association of dopamine transporter gene and schizophrenia in Korean population using multiple single nucleotide polymorphism markers. Progr Neuro-Psychopharmacology Biol Psychiatry 28:975-983
17. Rubie C, Schmidt F, Knapp M, Sprandel J, Wiegand C, Meyer J, Jungkunz G, Riederer P, Stöber G (2001) The human dopamine transporter gene: the 5′-flanking region reveals five diallelic polymorphic sites in a Caucasian population sample. Neurosci Lett 297:125-128
18. Kawarai T, Kawakami H, Yamamura Y, Nakamura S (1997) Structure and organization of the gene encoding human dopamine transporter. Gene 195:11-18
19. Weir BS (1996) Genetic data analysis II. Sinauer Associates, Sunderland, Massachusetts
20. Becker T, Knapp M (2004) Maximum-likelihood estimation of haplotype frequencies in nuclear families. Genet Epidemiol 27:21-32
21. Spielman RS, McGinnis RE, Ewens WJ (1993) Transmission test for linkage disequilibrium. The insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 52:506-512
22. Zhao H, Zhang S, Merikangas KR, Trixler M, Wildenauer DB, Sun F, Kidd KK (2000) Transmission/disequilibrium tests using multiple tightly linked markers. Am J Hum Genet 67:936-946
23. Kim JY, Jung IK, Han C, Cho SH, Kim L, Kim SH, Lee BH, Lee HJ, Kim YK (2005) Antipsychotics and dopamine transporter gene polymorphisms in delirium patients. Psychiatry Clin Neurosci 59:183-188
24. Knapp M (1999) A note on power approximations for the transmission/disequilibrium test. Am J Hum Genet 64:1177-1185
25. Purper-Ouakil D, Wohl M, Mouren MC, Verpillat P, Ades J, Gorwood P (2005) Meta-analysis of family-based association studies between the dopamine transporter gene and attention deficit hyperactivity disorder. Psychiatr Genet 15:53-59
26. Khodayari N, Garshasbi M, Fadai F, Rahimi A, Hafizi L, Ebrahimi A, Najmabadi H, Ohadi M (2004) Association analysis of the dopamine transporter (DAT1) core promoter polymorphism-67T variant with schizophrenia. Am J Med Genet 129:10-12
27. Greenwood TA, Kelsoe JR (2003) Promoter and intronic variants affect the transcriptional regulation of the human dopamine transporter gene. Genomics 82:511-519
28. Greenwood TA, Alexander M, Keck PE, McElroy S, Sadovnick AD, Remick RA, Kelsoe JR (2001) Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder. Am J Med Genet 105:145-151
29. Greenwood TA, Alexander M, Keck PE, McElroy S, Sadovnick AD, Remick RA, Shaw SH, Kelsoe JR (2002) Segmental linkage disequilibrium within the dopamine transporter gene. Mol Psychiatry 7:165-173
30. Greenwood TA, Schork NJ, Eskin E, Kelsoe JR (2006) Identification of additional variants within the human dopamine transporter gene provides further evidence for an association with bipolar disorder in two independent samples. Mol Psychiatry 11:125-133
31. Vandenbergh DJ, Thompson MD, Cook EH, Bendahhou E, Nguyen T, Krasowski MD, Zarrabian D, Comings D, Sellers EM, Tyndale RF, George SR, O'Dowd BF, Uhl GR (2000) Human dopamine transporter gene: coding region conservation among normal, Tourette's disorder, alcohol dependence and attention-deficit hyperactivity disorder populations. Mol Psychiatry 5:283-292
32. Grünhage F, Schulze TG, Müller DJ, Lanczik M, Franzek E, Albus M, Borrmann-Hassenbach M, Knapp M, Cichon S, Maier W, Rietschel M, Propping P, Nöthen MM (2000) Systematic screening for DNA sequence variation in the coding region of the human dopamine transporter gene (DAT1). Mol Psychiatry 5:275-282
33. Sacchetti P, Brownschidle LA, Granneman JG, Brannon MJ (1999) Characterization of the 5′-flanking region of the human dopamine transporter gene. Brain Res Mol Brain Res 74:167-174
34. Wang J, Bannon MJ (2005) Sp1 and Sp3 activate transcription of the human dopamine transporter gene. J Neurochem 93:474-482
35. Kouzmenko AP, Pereira AM, Singh BS (1997) Intronic sequences are involved in neural targeting of human dopamine transporter gene expression. Biochem Biophys Res Commun 240:807-811
36. Bouwman P, Philipsen S (2002) Regulation of the activity of Sp1-related transcription factors. Mol Cell Endocrinol 195:27-38
37. Ramji DP, Tadros MH, Hardon EM, Cortese R (1991) The transcription factor LF-A1 interacts with a bipartite recognition sequence in the promoter regions of several liver-specific genes. Nucleic Acids Res 19:1139-1146
38. Dynan WS, Tjian R (1983) Isolation of transcription factors that discriminate between different promoters recognized by RNA polymerase II. Cell 32:669-680
39. Liu Z, Thompson KS, Towle HC (1993) Carbohydrate regulation of the rat L-type pyruvate kinase gene requires two nuclear factors: LF-A1 and a member of the c-myc family. J Biol Chem 268:12787-12795
40. Peers B, Voz ML, Monget P, Mathy-Hartert M, Berwaer M, Belayew A, Martial JA (1990) Regulatory elements controlling pituitary-specific expression of the human prolactin gene. Mol Cell Biol 10:4690-4700
41. Li S, Crenshaw EB, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG (1990) Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 347:528-533
42. Rainbow LA, Rees SA, Shaikh MG, Shaw NJ, Cole T, Barrett TG, Kirk JM (2005) Mutation analysis of POUF-1, PROP-1 and HESX-1 show low frequency of mutations in children with sporadic forms of combined pituitary hormone deficiency and septo-optic dysplasia. Clin Endocrinol 62:163-168
43. Laakso A, Bergman J, Haaparanta M, Vilkman H, Solin O, Syvalahti E, Hietala J (2001) Decreased striatal dopamine transporter binding in vivo in chronic schizophrenia. Schizophr Res 52:115-120
44. Laruelle M, Abi-Dargham A, Gil R, Kegeles L, Innis R (1999) Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry 46:56-72
45. Stöber G, Sprandel J, Schmidt F, Faul T, Jabs B, Knapp M (2006) Association study of 5′-UTR polymorphisms of the human dopamine transporter gene with manic-depression (Bipolar Disorder accepted)